Aurinia Pharmaceuticals Inc AUPH

BullCapital Premium

41% retracement from head to neckline, so 41% from neckline puts it at $10.50. There are multiple horizontal support zones, see chart that also correspond to this zone $9.50 - 10.50. Greenleaf (CEO) is a complete clown. Issuing a statement last week that guidance will likely be aggressive then he issued guidance that was approximately 30% below the analysts. ...

Everestbull

Looks like a double bottom to me. risk reward in favor.

trackunison Pro+

Noticed Auph broke the 200ma did some quick analysis which means jack all but if we continue on this upward trend were likely to see a breakout soon. TA is based on pivot points with supports. Box means support confirmed over a few candles, ellipses is looking for past supports. This isn't investment advice this is some bored dude just jotting down risk to reward...

RocketTickers

AUPH: Aurinia Pharmaceuticals Inc. 2021-12-09 06:15:00 Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)

million1000000

Analysis of the instrument and the future outlook for its movement.

azap81

Watch for continuation of breakout, possible quick retest... Price Target = $40 range

LeLaf Premium

Bullish pennant on this pharma stock. Continued rise since Juns 2021. This pennant is not confirmed still. Will prabably be this coming monday. Price target = 42.77$ Stay Humble, Have fun, make money!

amr_youssef2

You can buy AUPH target 24 stop loss 17.39 Money management your responsibility. I recommend entering a maximum of 10% of the portfolio. Good luck

shkspr

NASDAQ:AUPH Possible Scenario: LONG Evidence: Price Action, I'm pretty sure about it, this is one of my main positions early morning. I expect it hit the Fibo level 100% at 25$ this week, most likely tomorrow Call options, strike 25$, 10/15/2021. *This is my idea and could be wrong 100%.

TheStockOdin Premium

Tons of money to played in this, constant up and down trend. Either short when it hits the channel trend line top, or go long at the channel bottom... I would rather be the bull in this situation though... so I would hold out on a entry.

stsoumpas

BULLISH WEDGE Been brewing since FDA approval of Voclosporin. Lots of reasons to speculate a buyout or possible merger with recent voluntary delisting from the TSX and remaining on NYSE. Excellent setup to be a cash cow. Target Price of $35 be EOY playing Oct Calls. PFE and MRNA are LOADED with cash and you know they're sniffing out opportunities and would love...

20:00

iCantw84it Pro+

This is a video I made to cover all the plays made about a month ago up until about two weeks ago. I cut off half way through and honestly I thought it didn't record any of it. So I am posting it now. and I will pick up where it left off probably tomorrow. If these have helped you trade please like and follow. by iCantw84it 05.26.2021

shkspr

NASDAQ:AUPH Possible Scenario: LONG Evidence: Price Action TP1~ 12.5$. TP2 ~14.25$ Call options, Strike 14$, 07/16/21 Call options, Strike 15$, 07/16/21 * This is my idea and could be wrong 100%

Brain_Storm1111

School of cumulative chaos measurements and waves 23.6

Brain_Storm1111

Transporter 23 Back support

04:57

daytraderrockstar

Its been a long time coming but I have identified a long term trend line that will be a great entry. Its here now and woth a entry. I will be adding on Monday

rbswingtrader Premium

Given its recent FDA approvals ir.auriniapharma.com , we will see this breaking out in short time and head towards $30.

des Pro+

Spike from FDA approval. Anticipate pull back to 61 fib level. MT - price target is 61 feb extension level.